The 510(k) decision clears the device for use with ultra-rapid-acting insulins from Eli Lilly and Novo Nordisk.

Medtronic (NYSE:MDT) today announced three U.S. milestones expanding access to its MiniMed 780G automated insulin delivery ...

Beneficiaries of Medicare and Medicare Advantage can now obtain the MiniMed 780G system combined with the Instinct sensor.

Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on Wednesday.

The US Food and Drug Administration issued a warning on Thursday about possible risk of hacking for some diabetes patients' insulin pumps. Certain insulin pumps from Medtronic MiniMed have been ...

Medtronic, which develops, manufactures and sells medical therapy devices, has issued a voluntary recall of its MiniMed 600 series or 700 series insulin pumps due to the pump's potentially shortened ...

It’s traditionally been particularly difficult to manage diabetes in highly active, still-developing children, but increasingly advanced glucose monitors and insulin delivery systems are aiming to ...

Please provide your email address to receive an email when new articles are posted on . All Medtronic MiniMed 600 and 700 series insulin pumps have been recalled due to an increased risk for short ...

Medtronic plc (NYSE:MDT) initiated a recall Friday to address potential battery life issues with its insulin pumps. As of July 31, the company has advised customers to pay close attention to their ...

Those who rely on certain Medtronic MiniMed insulin pump models to administer insulin could be at risk, according to the U.S. Food and Drug Administration. On June 27, the FDA issued a recall on 11 ...

Medtronic is warning of a potential safety risk involving its MiniMed insulin pumps that has led to at least one hospitalization and one death, according to the Star Tribune. Medtronic said its ...

GRAND RAPIDS, Mich. — Medtronic is recalling MiniMed insulin pumps for incorrect insulin dosing which according to the FDA, can cause serious injury or death. The FDA says this is a class 1 recall, ...